What is the price of GeneOne Life Science, Inc. (011000)

The price of GeneOne Life Science, Inc. (011000) is $1.85

What is the market cap of GeneOne Life Science, Inc. (011000)

The market cap of GeneOne Life Science, Inc. (011000) is $32.07M

GeneOne Life Science, Inc. (011000) Shares Outstanding

GeneOne Life Science, Inc., a biopharmaceutical firm headquartered in Seoul, South Korea, was founded in 1976. The company focuses on the innovation and manufacturing of gene-based biomedical products. Its developmental pipeline features several candidates: GLS-1027 is in Phase I for nephropathy and inflammatory conditions, and also in Phase II trials for COVID-19. Similarly, GLS-1200 is being tested in Phase II for both Rhinosinusitis and COVID-19. Other compounds under development include GLS-3000 and GLS-5310 for SARS-CoV-2, GLS-5100 targeting VZV-Shingles, and GLS-5140 for SFTS. The company is also advancing GLS-5300 in Phase II for MERS, GLS-5700 in Phase I for Zika, and GLS-6150 in Phase I for hepatitis C, alongside GLS-6100 which is in a pre-clinical stage for hepatitis C. Additionally, through its subsidiary VGXI, Inc., GeneOne Life Science offers contract manufacturing services for nucleic acid-based products, specifically DNA plasmids and mRNA, under cGMP standards. The company adopted its current name in April 2014, having previously been known as VGX International Inc.

Year	Shares Outstanding	Change
Not enough data for the provided dates.

Year

Shares Outstanding

Change

Not enough data for the provided dates.

Company	Shares Outstanding	Difference	Country
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Moderna, Inc. MRNA.US	396.00M	-	US
Argenx SE ARGX.US	62.19M	-	NL
CSL Limited CSL.AX	483.58M	-	AU
Lonza Group AG LONN.SW	-	-	CH

Company

Shares Outstanding

Difference

Country